Hologic Statistics

Total Valuation

Hologic has a market cap or net worth of GBP 11.45 billion. The enterprise value is 11.89 billion.

Market Cap	11.45B
Enterprise Value	11.89B

Important Dates

The last earnings date was Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-4.48%
Shares Change (QoQ)	-1.64%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	222.28M

Valuation Ratios

The trailing PE ratio is 19.37.

PE Ratio	19.37
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	25.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.42, with an EV/FCF ratio of 13.24.

EV / Earnings	20.12
EV / Sales	3.72
EV / EBITDA	11.42
EV / EBIT	15.44
EV / FCF	13.24

Financial Position

The company has a current ratio of 3.49, with a Debt / Equity ratio of 0.53.

Current Ratio	3.49
Quick Ratio	2.60
Debt / Equity	0.53
Debt / EBITDA	1.92
Debt / FCF	2.25
Interest Coverage	7.72

Financial Efficiency

Return on equity (ROE) is 15.78% and return on invested capital (ROIC) is 8.40%.

Return on Equity (ROE)	15.78%
Return on Assets (ROA)	7.10%
Return on Invested Capital (ROIC)	8.40%
Return on Capital Employed (ROCE)	12.65%
Revenue Per Employee	454,194
Profits Per Employee	83,664
Employee Count	7,063
Asset Turnover	0.47
Inventory Turnover	2.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.78% in the last 52 weeks. The beta is 0.98, so Hologic's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-13.78%
50-Day Moving Average	70.63
200-Day Moving Average	76.46
Relative Strength Index (RSI)	31.36
Average Volume (20 Days)	753

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.42

Income Statement

In the last 12 months, Hologic had revenue of GBP 3.21 billion and earned 590.92 million in profits. Earnings per share was 2.51.

Revenue	3.21B
Gross Profit	1.95B
Operating Income	776.14M
Pretax Income	731.74M
Net Income	590.92M
EBITDA	1.02B
EBIT	776.14M
Earnings Per Share (EPS)	2.51

Full Income Statement

Balance Sheet

The company has 1.57 billion in cash and 2.02 billion in debt, giving a net cash position of -446.37 million.

Cash & Cash Equivalents	1.57B
Total Debt	2.02B
Net Cash	-446.37M
Net Cash Per Share	n/a
Equity (Book Value)	3.79B
Book Value Per Share	16.81
Working Capital	1.98B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 996.39 million and capital expenditures -98.33 million, giving a free cash flow of 898.06 million.

Operating Cash Flow	996.39M
Capital Expenditures	-98.33M
Free Cash Flow	898.06M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.93%, with operating and profit margins of 24.19% and 18.42%.

Gross Margin	60.93%
Operating Margin	24.19%
Pretax Margin	22.81%
Profit Margin	18.42%
EBITDA Margin	31.67%
EBIT Margin	24.19%
FCF Margin	27.99%

Dividends & Yields

Hologic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.48%
Shareholder Yield	4.48%
Earnings Yield	5.16%
FCF Yield	7.85%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hologic has an Altman Z-Score of 4.38.

Altman Z-Score	4.38
Piotroski F-Score	n/a